EXPLAINER: New drug slows Alzheimer's but comes with caveats

WASHINGTON (AP) — A new Alzheimer’s drug is hitting the market — the first with clear-cut evidence that it can slow, by several months, the mind-robbing disease. It's a long-needed new treatment, but experts also are voicing a lot of caution: The...